• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • WORLD EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • WORLD EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Technology Market
Technology News
Technology Stocks
  • Technology Market
  • Technology News
  • Technology Stocks

BIO-key International Enhances Secure Biometric Authentication with HealthIDx Partnership

Written by Morag Mcgreevey
|
Jan. 07, 2016 11:00AM PST

BIO-key International, Inc. (OTCQB: BKYI) has improved its offering of secure biometric authentication by adding robust identity proofing services and optional hosted authentication services in partnership with HealthIDx, a Credential Services Provider (CSP).

BIO-key International, Inc. (OTCQB: BKYI) has improved its offering of secure biometric authentication by adding robust identity proofing services and optional hosted authentication services in partnership with HealthIDx, a Credential Services Provider (CSP).
According to the press release:

This enhancement significantly expands the markets for BIO-key’s authentication products, and will allow many more health systems to avail themselves of BIO-key’s superior user experience for ePrescribing authentication. While the immediate beneficiaries are in healthcare, non-healthcare market customers can also leverage BIO-key’s identity proofing service to ensure positive identity of enrolled individuals into their BIO-key applications.
“We’re excited to be partnering with BIO-key in this important effort to increase the security, ease of use, and cost effectiveness of ePrescribing solutions,” said Scott Lowry, CEO of HealthIDx.
BIO-key has a strong track record providing “biometric plus” two-factor authentication solutions with its ID Director family of products, providing seamless integration into ePrescribing platforms from EPIC and Allscripts, with more integrations in development. Healthcare customers choose BIO-key because of the day-to-day operational impact of its outstanding National Institute of Standards and Technology (NIST) accuracy tests, scalable 1-to-many search, and device interoperability. NIST’s reports (https://www.nist.gov/itl/iad/ig/pftii_results.cfm) demonstrate that BIO-key’s accuracy results are orders of magnitude better than competitive offerings being sold at higher prices. BIO-key’s superior accuracy directly impacts prescribers every day with an improved biometric experience, and allows the highest standards of security to be met without compromise.

Click here to read the full press release.

 

The Conversation (0)

Go Deeper

AI Powered
Scientist pouring blue liquid from a test tube into a flask in a lab.

Biotech Market Forecast: Top Trends for Biotech in 2026

ImmunityBio Inc.

ImmunityBio Inc.

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES